Papers: 14 Jan 2013 - 21 Jan 2013
Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis.
A Genome-Wide Integrative Genomic Study Localizes Genetic Factors Influencing Antibodies against Epstein-Barr Virus Nuclear Antigen 1 (EBNA-1).
[Prognostic value of aquaporin-4 antibody in patients of inflammatory demyelinating diseases in central nervous system].
Nephrotic syndrome in multiple sclerosis patients who had undergone long-term interferon β-1b therapy.
Load-dependent dysfunction of the putamen during attentional processing in patients with clinically isolated syndrome suggestive of multiple sclerosis.
[Clinical and magnetic resonance imaging features of neuromyelitis optics with positive anti-nuclear antibody serum].
[Clinical features and neuroimaging findings of 12 patients with acute disseminated encephalomyelitis involved in corpus callosum].
Presumptive Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis after Natalizumab Therapy.
Acute necrotizing encephalopathy (ANE1): rare autosomal-dominant disorder presenting as acute transverse myelitis.
Rare MEFV variants are not associated with risk to develop multiple sclerosis and severity of disease.
A guide to facilitate the early treatment of patients with idiopathic demyelinating disease (multiple sclerosis and neuromyelitis optica).
Reduced fingolimod dosage treatment for patients with multiple sclerosis and lymphopenia or neutropenia.
CXCL13 is a biomarker of inflammation in multiple sclerosis, neuromyelitis optica, and other neurological conditions.
The effect of Nintendo(R) Wii(R) on balance in people with multiple sclerosis: a pilot randomized control study.
Induction of atypical EAE mediated by transgenic production of IL-6 in astrocytes in the absence of systemic IL-6.
Symptoms Related to Tumor Necrosis Factor Receptor 1-associated Periodic Syndrome, Multiple Sclerosis, and Severe Rheumatoid Arthritis in Patients Carrying the TNF Receptor Superfamily 1A D12E/p.Asp41Glu Mutation.
Central Nervous System Expression and PET Imaging of the Translocator Protein in Relapsing-Remitting Experimental Autoimmune Encephalomyelitis.
Update on reproductive safety of current and emerging disease-modifying therapies for multiple sclerosis.
No Regional Gray Matter Atrophy Differences between Pediatric- and Adult-Onset Relapsing-Remitting Multiple Sclerosis.
Immunosuppressive monoclonal antibody to CD64 from patients with long-term stable multiple sclerosis.
Prevalence and natural history of pain in adults with multiple sclerosis: Systematic review and meta-analysis.
Getting beyond the ganglion cell: morphometric adjustments for retinal optical coherence tomography in multiple sclerosis.
Charcot-Marie-Tooth type 1C disease coexisting with progressive multiple sclerosis: a study of an overlapping syndrome.
Acute liver toxicity due to methylprednisolone: Consider this diagnosis in the context of autoimmunity.
Synthesis and characterization of a novel Gd-based contrast agent for magnetic resonance imaging of myelination.
DemTect, PANDA, EASY, and MUSIC: Cognitive Screening Tools with Age Correction and Weighting of Subtests According to Their Sensitivity and Specificity.
TWEAK/Fn14 pathway modulates properties of a human microvascular endothelial cell model of blood brain barrier.
Attenuation of corpus callosum axon myelination and remyelination in the absence of circulating sex hormones.
Autoimmune disease in people with multiple sclerosis and their relatives: a systematic review and meta-analysis.
Environmental Factors Associated with Disease Progression after the First Demyelinating Event: Results from the Multi-Center SET Study.
The brain microvascular endothelium supports T cell proliferation and has potential for alloantigen presentation.
Fatigue, tiredness, lack of energy, and sleepiness in multiple sclerosis patients referred for clinical polysomnography.